Last reviewed · How we verify
KyungBangn Gamisoyosan
Gamisoyosan is a traditional herbal medicine formulation that modulates immune and inflammatory responses through multiple botanical constituents.
Gamisoyosan is a traditional herbal medicine formulation that modulates immune and inflammatory responses through multiple botanical constituents. Used for Inflammatory bowel disease or related gastrointestinal inflammatory conditions.
At a glance
| Generic name | KyungBangn Gamisoyosan |
|---|---|
| Also known as | standard code for item: 200005591 |
| Sponsor | Korea Health Industry Development Institute |
| Modality | Small molecule |
| Therapeutic area | Immunology/Gastroenterology |
| Phase | Phase 3 |
Mechanism of action
Gamisoyosan is a multi-component herbal preparation derived from traditional Korean medicine. It contains several medicinal plants that are believed to work synergistically to regulate immune function, reduce inflammation, and support gastrointestinal health. The exact molecular mechanisms remain incompletely characterized but likely involve modulation of cytokine production and immune cell activity.
Approved indications
- Inflammatory bowel disease or related gastrointestinal inflammatory conditions
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- KyungBangn Gamisoyosan CI brief — competitive landscape report
- KyungBangn Gamisoyosan updates RSS · CI watch RSS
- Korea Health Industry Development Institute portfolio CI